BMS Sighs In Relief As Opdivo Returns To Sales Growth

 
• By Joseph Haas
  
Bristol-Myers-Squib_685347493_1200.jpg
BMS reports 16% year-over-year sales growth for Q2 2021
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business